Test ID GIP Gastrointestinal Pathogen Panel, PCR, Feces
Useful For
Rapid detection of gastrointestinal infections caused by:
-Campylobacter species (Campylobacter jejuni/Campylobacter coli/Campylobacter upsaliensis)
-Clostridium difficile toxin A/B
-Plesiomonas shigelloides
-Salmonella species
-Vibrio species (Vibrio parahaemolyticus, Vibrio vulnificus, Vibrio cholerae)
-Vibrio cholerae
-Yersinia enterocolitica
-Enteroaggregative Escherichia coli (EAEC)
-Enteropathogenic Escherichia coli (EPEC)
-Enterotoxigenic Escherichia coli (ETEC)
-Shiga toxin
-Escherichia coli O157
-Shigella/Enteroinvasive Escherichia coli (EIEC)
-Cryptosporidium species
-Cyclospora cayetanensis
-Entamoeba histolytica
-Giardia
-Adenovirus F 40/41
-Astrovirus
-Norovirus GI/GII
-Rotavirus A
-Sapovirus
Testing Algorithm
The following algorithms are available in Special Instructions:
-Parasitic Investigation of Stool Specimens Algorithm
-Laboratory Testing for Infectious Causes of Diarrhea
Special Instructions
Method Name
Multiplex Polymerase Chain Reaction (PCR)
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)
Reporting Name
GI Pathogen Panel, PCR, FSpecimen Type
FecalSpecimen must arrive within 96 hours of collection.
Specimen Type: Preserved Stool
Container/Tube: Cary-Blair transport system is required: Specific for recovery of enteric pathogens from fecal specimens (15 mL of non-nutritive transport medium containing phenol red as a pH indicator, either Cary-Blair or Para-Pak C and S [T058])
Specimen Volume: Representative portion of stool
Collection Instructions: Collect fresh stool and submit 1 gram or 5 mL in container with transport medium.
Specimen Minimum Volume
1 mL
Specimen Stability Information
Specimen Type | Temperature | Time |
---|---|---|
Fecal | Ambient (preferred) | 4 days |
Refrigerated | 4 days |
Clinical Information
Acute diarrheal syndromes are usually self-limiting, but may be complicated by dehydration, vomiting, and/or fever. Diagnostic testing and treatment may be required in some instances. Many bacterial enteric infections in the United States originate within the food supply chain. According to the CDC, in 2012 there were 19,531 laboratory-confirmed cases of infection with pathogens potentially transmitted through food in the United States; the number of infections, by pathogen, were as follows: Salmonella species (7,800), Campylobacter species (6,793), Shigella species (2,138), Cryptosporidium species (1,234), Shiga toxin-producing Escherichia coli non-O157 (551), Shiga toxin-producing Escherichia coli O157 (531), Vibrio species (193), Yersinia species (155), and Cyclospora cayetanensis (15). Giardia may also be transmitted through ingestion of contaminated food and water. There were 15,178 cases of giardiasis reported to the CDC in 2012. Since the clinical presentation may be very similar for many of these bacterial, viral, and parasitic pathogens, laboratory testing is required for definitive identification of the causative agent.
Rapid multiplex panel detection of the most common agents of bacterial, viral, and parasitic enteric infections directly from stool specimens is sensitive, specific, and provides same-day results, obviating the need for culture, antigen testing, microscopy, or individual nucleic acid amplification tests.
See Parasitic Investigation of Stool Specimens Algorithm and Laboratory Testing for Infectious Causes of Diarrhea in Special Instructions for other diagnostic tests that may be of value in evaluating patients with diarrhea.
Reference Values
Negative (for all targets)
Cautions
The detection of microbial DNA or RNA is dependent upon proper sample collection, handling, transportation, storage, and preparation. There is a risk of false-negative results due to the presence of strains with sequence variability or genetic rearrangements in the target regions of the assays.
This test is not recommended as a test of cure.
Repeat testing should not be performed on samples collected less than 7 days apart.
The presence of blood or mucous in the sample may interfere with testing.
It is not recommended that VIBC / Vibrio Culture, Stool; ROTA / Rotavirus Antigen, Feces; LADV / Adenovirus, Molecular Detection, PCR; GIAR / Giardia Antigen, Feces; CRYPS / Cryptosporidium Antigen, Feces; CYCL / Cyclospora Stain; STL / Enteric Pathogens Culture, Stool; STFRP / Shiga Toxin, Molecular Detection, PCR, Feces; or CDFRP / Clostridium difficile Toxin, Molecular Detection, PCR, Feces be concomitantly ordered if this test is ordered.
The following information is provided by the test manufacturer:
Campylobacter species: Detects but does not differentiate Campylobacter jejuni, Campylobacter coli, and Campylobacter upsaliensis. Other species will not be detected. Helicobacter pullorum may cross react.
Clostridium difficile: Detects but does not differentiate toxin A gene (tcdA) and toxin B gene (tcdB). A positive result may reflect asymptomatic carriage or Clostridium difficile-associated diarrhea.
Salmonella species: Detects but does not differentiate Salmonella enterica and Salmonella bongori. Cross-reactivity may occur with some strains of Escherichia coli, which have the cryptic ETT2 type-III secretion system.
Vibrio species: Detects but does not differentiate Vibrio parahaemolyticus and Vibrio vulnificus. The assay may also react with less common Vibrio species (ie, Vibrio alginolyticus, Vibrio fluvialis, and Vibrio mimicus). Vibrio cholerae is specifically listed when detected. Grimontia hollisae may cross react.
Yersinia enterocolitica: Detects but does not differentiate known serotypes/biotypes. Yersinia kristensenii, Yersinia Frederiksenii, and Yersinia intermedia may cross-react at high levels.
Diarrheagenic Escherichia coli: Detects genetic determinants associated with classic diarrheagenic Escherichia coli/Shigella pathotypes. Transfer of these genes between organisms has been documented; therefore, detected results for multiple diarrheagenic Escherichia coli/Shigella may be due to the presence of multiple pathotypes or a single strain containing the genes characteristic of multiple pathotypes.
Enteroaggregative Escherichia coli (EAEC): Detects but does not differentiate 2 gene targets typically associated with enteroaggregative Escherichia coli; the aggR regulatory gene and the putative outer membrane protein, aatA, both located on the partially-conserved pAA plasmid. pAA is not present in all strains phenotypically identified as EAEC, and not all pAA plasmids carry aggR and aatA genes; therefore, the assay will not detect all members of this diverse pathotype, but is likely to detect most pathogenic strains.
Enterotoxigenic Escherichia coli (ETEC): Detects but does not differentiate heat-labile (LT) enterotoxin (ltA) and 2 heat-stable (ST) enterotoxin variants (st1a and st1b). Cross-reactivity may occur with strains of Hafnia alvei, Citrobacter koseri, Citrobacter sedlakii and Cedecea davisae. LT-II and the STB/ST2 toxins are not detected.
Enteropathogenic Escherichia coli (EPEC): Detects eae gene but does not differentiate typical and atypical EPEC. The LEE pathogenicity island, which includes the eae gene, is also found in some Shiga toxin-producing Escherichia coli (STEC; O157 and non-O157 strains). Therefore, the results of the eae assay (positive or negative) are only reported when STEC is not detected. When STEC is detected, EPEC will not be reported, regardless of the EPEC assay result. Consequently, the assay cannot distinguish between STEC containing eae and a co-infection of EPEC and STEC. Rare instances of other organisms carrying eae have been documented (eg, Aeromonas species, Citrobacter species, Escherichia albertii, Shigella boydii). Others assays target bfp to detect EPEC and, if positive, reflex to eae detection to characterize isolates as typical or atypical EPEC. The bfp gene is not used to detect EPEC in this assay. For the reasons described above, EPEC may be missed or overcalled.
Shiga toxin-producing Escherichia coli (STEC): Detects but does not differentiate Shiga toxin 1 (stx1) and Shiga toxin 2 (stx2) sequences. Shiga toxin-positive results indicate the likely presence of Shiga toxin-producing Escherichia coli. Rare instances of detection of Shiga-like toxin genes in other genera/species have been reported (eg, Aeromonas caviae, Acinetobacter haemolyticus, Shigella sonnei, Enterobacter cloacae, Citrobacter freundii, Klebsiella pneumoniae).
Escherichia coli O157: The Escherichia coli O157 assay is not reported as detected unless a Shiga-like toxin gene is also detected. The assay cannot distinguish between infections with a single toxigenic STEC O157 or rare co-infections of STEC (non-O157) with an stx1/stx2-negative Escherichia coli O157.
Shigella/Enteroinvasive E. coli (EIEC): Detects but does not differentiate Shigella species from enteroinvasive Escherichia coli.
Cryptosporidium species: Detects but does not differentiate approximately 23 different Cryptosporidium species, including the most common species (eg, Cryptosporidium hominis and Cryptosporidium parvum), as well as less common species (eg, Cryptosporidium meleagridis, Cryptosporidium felis, Cryptosporidium canis, Cryptosporidium cuniculus, Cryptosporidium muris, and Cryptosporidium suis), but is not expected to detect the very rare species Cryptosporidium bovis, Cryptosporidium ryanae and Cryptosporidium xiaoi.
Entamoeba histolytica: Detects Entamoeba histolytica. Entamoeba dispar present in high levels may cross-react.
Giardia: Detects Giardia lamblia (also known as Giardia intestinalis, Giardia duodenalis). A very low frequency of cross-reactivity with the commensal microorganisms Bifidobacterium and Ruminococcus species was observed in the clinical evaluation.
Adenovirus F40/41: Detects but does not differentiate F40 and F41. Does not detect respiratory adenovirus species, such as B, C, and E.
Astrovirus: Detects but does not differentiate 8 subtypes (HAstV1-8).
Norovirus GI/GII: Detects but does not differentiate GI and GII. Does not detect genogroup GIV, nonhuman genogroups, or closely related Caliciviruses.
Rotavirus: Detects all strains of rotavirus A. In silico sequence analysis indicates that these assays will not cross-react with rotavirus B and C, which are less common in human disease, or rotavirus D, E, and F, which have not been found in humans. Recent oral rotavirus A vaccines may result in patients passing the virus in stool and be detectable in stool PCR testing. Contamination of specimens with vaccine can cause false-positive rotavirus PCR results. Specimens should not be collected or processed in areas that are exposed to rotavirus A vaccine material.
Sapovirus: Detects but does not differentiate genogroups I, II, IV, V. Genogroup III will not be detected.
Day(s) Performed
Monday through Sunday; Continuously
Report Available
1 dayPerforming Laboratory

Test Classification
This test has been cleared or approved by the U.S. Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
87507